Kinase Chemistry – Just a year and a half behind the times.

Tarceva ®

Posted by kinasepro on April 8, 2007

Tarceva ®, erlotinib hydrochloride, OSI-774


Discovery: Pfizer WO/1996/30347. Pfizer turned over the rights to OSI to meet U.S. FTC requirements related to Pfizer’s merger with Warner-Lambert in June 2000. The drug is jointly marketted by Genentech, and OSI.
US Approval: November 2004;

PDB: 1M17


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: